Literature DB >> 9725466

Dissolution kinetics for coprecipitates of diflunisal with PVP K30.

C Rodríguez-Espinosa1, M C Martínez-Ohárriz, C Martín, M M Goñi, I Vélaz, M Sánchez.   

Abstract

Diflunisal is a nonsteroidal anti-inflammatory drug that is poorly soluble in water. The present study describes the formulation of solid dispersions of the drug designed to increase its solubility. X-ray diffraction and DSC were used to examine the physico-chemical characteristics of solid dispersions of diflunisal and polyvinylpyrrolidone (PVP) prepared by the solvent method, using percentage proportional compositions ranging from 20:80 to 50:50. X-ray diffraction analysis detected that diflunisal is present in solid dispersions in crystalline or amorphous state depending on the PVP content. The thermal behavior of diflunisal observed in the DSC curves of solid dispersion systems, was attributed to a solid-state interaction. The increased release of the PVP-drug dispersion as compared to the PVP-drug physical mixture was attributed to the formation of a complex resulting from the interaction of the drug and the polymer.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9725466     DOI: 10.1007/BF03189324

Source DB:  PubMed          Journal:  Eur J Drug Metab Pharmacokinet        ISSN: 0378-7966            Impact factor:   2.441


  7 in total

1.  The influence of polyvinylpyrrolidone on the solution and bioavailability of hydrochlorothiazide.

Authors:  O I Corrigan; R F Timoney; M J Whelan
Journal:  J Pharm Pharmacol       Date:  1976-09       Impact factor: 3.765

2.  Dissolution rates of high energy sulfathiazole--povidone coprecipitates II: characterization of form of drug controlling its dissolution rate via solubility studies.

Authors:  A P Simonelli; S C Mehta; W I Higuchi
Journal:  J Pharm Sci       Date:  1976-03       Impact factor: 3.534

Review 3.  Pharmaceutical applications of solid dispersion systems.

Authors:  W L Chiou; S Riegelman
Journal:  J Pharm Sci       Date:  1971-09       Impact factor: 3.534

4.  Polymorphism of diflunisal: isolation and solid-state characteristics of a new crystal form.

Authors:  M C Martínez-Ohárriz; C Martín; M M Goñi; C Rodríguez-Espinosa; M C Tros de Ilarduya-Apaolaza; M Sánchez
Journal:  J Pharm Sci       Date:  1994-02       Impact factor: 3.534

5.  Dissolution mechanisms of drug-polyvinylpyrrolidone coprecipitates in aqueous solution.

Authors:  H Sekikawa; M Nakano; T Arita
Journal:  Chem Pharm Bull (Tokyo)       Date:  1979-05       Impact factor: 1.645

6.  Improved holder for intrinsic dissolution rate studies.

Authors:  J Wood; J Syarto; H Letterman
Journal:  J Pharm Sci       Date:  1965-07       Impact factor: 3.534

7.  Dissolution rates of high energy polyvinylpyrrolidone (PVP)-sulfathiazole coprecipitates.

Authors:  A P Simonelli; S C Mehta; W I Higuchi
Journal:  J Pharm Sci       Date:  1969-05       Impact factor: 3.534

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.